ClinicalTrials.gov record
Not listed Phase 1 Interventional

Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features

ClinicalTrials.gov ID: NCT00314925

Public ClinicalTrials.gov record NCT00314925. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 6:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase I Dose-Escalation Study of Seneca Valley Virus (SVV-001), a Replication-Competent Picornavirus, in Patients With Advanced Solid Tumors With Neuroendocrine Features

Study identification

NCT ID
NCT00314925
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Neotropix
Industry
Enrollment
60 participants

Conditions and interventions

Interventions

  • Seneca Valley Virus (biological agent) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2006
Primary completion
Nov 30, 2008
Completion
Nov 30, 2008
Last update posted
Feb 24, 2010

2006 – 2008

United States locations

U.S. sites
10
U.S. states
9
U.S. cities
10
Facility City State ZIP Site status
Cancer Centers of Florida Ocoee Florida 34761
Central Indiana Cancer Centers Indianapolis Indiana 46219
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland 21231
New York Oncology Hematology P.C. Albany New York 12208
Dayton Oncology & Hematology, P.A . Kettering Ohio 45409
Cancer Centers of the Carolinas Greenville South Carolina 29605
Mary Crowley Research Center Dallas Texas 75201
Tyler Cancer Center Tyler Texas 75702
Virginia Oncology Associates Norfolk Virginia 23502
Northwest Cancer Specialists - Vancouver Cancer Center Vancouver Washington 98684

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00314925, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 24, 2010 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00314925 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →